ArticleslgStudy

biology

TOL-463

TOL-463 is a biology topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand TOL-463 rather than just read about it. In short: TOL-463, also known as boric acid/ethylenediaminetetraacetic acid or boric acid/EDTA, is an anti-infective medication which is under development for the treatment of bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC) (vaginal yeast infection). It is a boric acid-based vaginal anti-infective enhanced with ethylenediaminetetraacetic acid (EDTA) which was designed to have improved activity against vaginal bact…

TOL-463 — main illustration
TOL-463 — illustration

Key takeaways

  • TOL-463 belongs to biology; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect TOL-463 to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of TOL-463 from memory before moving on to harder problems.

Reference excerpt

TOL-463, also known as boric acid/ethylenediaminetetraacetic acid or boric acid/EDTA, is an anti-infective medication which is under development for the treatment of bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC) (vaginal yeast infection). It is a boric acid-based vaginal anti-infective enhanced with ethylenediaminetetraacetic acid (EDTA) which was designed to have improved activity against vaginal bacterial and fungal biofilms while sparing protective lactobacilli. EDTA enhances the antimicrobial activity of boric acid and improves its efficacy against relevant biofilms. In a small phase 2 randomized controlled trial, TOL-463 as an insert or gel achieved clinical cure rates of 50 to 59% against BV and 81 to 92% against VVC in women who had one or both conditions. It was effective and safe in the study, though it was without indication of superiority over other antifungal medications for VVC. The cure rates against BV with TOL-463 were said to be comparable to those with recently approved antibiotic treatments like single-dose oral secnidazole (58%) and single-dose metronidazole vaginal gel (41%). As of July 2022, TOL-463 is in phase 2 clinical trials for the treatment of BV and VVC. It was originated by Toltec Pharmaceuticals and is under development by Toltec Pharmaceuticals and the National Institute of Allergy and Infectious Diseases. There have been no developmental updates since May 2019.

See also LACTIN-V

References

External links TOL-463 - AdisInsight

Illustrations

TOL-463 illustration
TOL-463 illustration

Worked examples

Example 1 — a first encounter with TOL-463

Start with the simplest possible case. Write down what TOL-463 claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In biology, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to TOL-463 before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about TOL-463 ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of TOL-463

In research
TOL-463 appears in biology research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses TOL-463 in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
TOL-463 is common in secondary-school and first-year university syllabi. It links to neighbouring topics Anti-infective agent stubs, Antifungals, Antiseptics, so understanding it makes those chapters shorter.
In everyday life
Look for TOL-463 outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study TOL-463 in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what TOL-463 means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain TOL-463 out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is TOL-463 in simple terms?

TOL-463, also known as boric acid/ethylenediaminetetraacetic acid or boric acid/EDTA, is an anti-infective medication which is under development for the treatment of bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC) (vaginal yeast infection). It is a boric acid-based vaginal anti-infectiv…

Why does TOL-463 matter?

Because it connects several biology ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study TOL-463?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on TOL-463.

Tags

  • Anti-infective agent stubs
  • Antifungals
  • Antiseptics
  • Experimental urogynecological drugs
  • Genito-urinary system drug stubs

Keep exploring